Search

The overall market has topped out in the last month. But many of the slower-moving and more value-oriented stocks didn’t get the memo.

It’s a period of offsets for the market. The excitement of a booming recovery is offset by the fact that the market is looking six months ahead to the end of the year when growth is slowing.

The market is selling off on Tuesday after briefly recovering last week. The latest worry is the debt limit. While this issue is likely to be resolved without any disaster one way or another, it puts a negative weight on an already teetering market.

The market still looks strong. The S&P 500 is on pace for a 3% gain in the month of August, which would be the seventh straight monthly gain. The index is already up 20% for the year.

It was a glorious October. The S&P 500 was up about 7% for the month, more than making up for September’s 4.8% decline. Now what?

The S&P 500 is at a new all-time high. While the market hasn’t been exciting compared to earlier this year, it’s clearly moving the right way.

September lived up to its bad reputation. The S&P 500 fell 4.8% for the month. But September is over. Now it’s October, which is historically only the second-worst month of the year. What now?

Over the summer, the strong economy prevailed over concerns about the virus. And the market drifted higher. We’ll see if the scales get tipped the other way in this historically tough month for the market.

The heart of the Contrary Opinion Forum is the talks by some of the best independent thinkers in the investment business.

All eyes are on the Fed. Sure, there’s inflation and Omicron and some other stuff. But Wall Street types mostly care about the Fed.

In today’s note, we discuss the recent earnings reports from Bayer AG (BAYRY), Duluth Holdings (DLTH) and LB Foster (FSTR).

AbbVie’s (ABBV) earnings failed to impress last week, the stock is stuck in a trading range with a slight downward bias, and the biotech rally has failed—or at least been delayed—once again.

No matter where you are in your investing journey, this comprehensive list has a saving, spending, or investing app that can help you reach your goals.

A low-yield market environment has been making it tough to generate income these days. Watch Tom Hutchinson, Chief Analyst of Cabot Dividend Investor as he talks about how to deal with this income crisis.
During this FREE webinar recording he explains how to get a double-digit annual income from supplementing dividend stocks and income paying securities with timely purchases and strategic investments. Tom also tells you about two high-yield stocks to get you started.

Tom Hutchinson, Chief Analyst of Cabot Dividend Investor, talked about dividend stocks and the current market. PLUS Tom shared a couple of his favorite high-growth, high-yield stocks.

Tim Lutts, CEO of Cabot Wealth Network, talk about current conditions in this (hopefully) post-corona crash market and shares high-potential growth stocks.

Tyler Laundon, Chief Analyst of Cabot Small-Cap Stocks and Cabot Early Opportunities speaks about Software Stocks.

Among the topics he covers:
* A look at current software stock valuations
* Software in context: Trends over the last 25 years
* Software today: More options than ever
* Software stock opportunities for 2021

The rally sputtered. And it’s all about interest rates.

Investors had been factoring in falling interest rates and a soft landing. But now, investors are increasingly expecting no landing and continued high rates. Recent strong economic numbers, along with higher-than-expected inflation, are changing the perception.

It looks like these high rates will stick around for a while. And most stocks don’t like high rates. But not all. There are some companies that actually thrive with higher interest rates. And that creates opportunity. In this issue, I highlight a stock that pays a massive dividend generated by these high interest rates. As income investors, we can reap the bounty.